EDSA
Price:
$7.35
Market Cap:
$65.36M
Edesa Biotech, Inc. is a biopharmaceutical firm focused on discovering, developing, and commercializing clinical-stage treatments for inflammatory and immune system disorders where current medical options are inadequate. The company's key pipeline assets include EB05, a monoclonal antibody undergoing a Phase 3 clinical trial for acute respiratory distress syndrome (ARDS) in COVID-19 patients, and EB01, a topical therapy in a Phase 2B clinical study addressing chronic allergic contact dermatitis. Furthermore, Edesa has a licensing collaboration with NovImmune SA to advance monoclonal antibodies specifically designed to target TLR4 and CXCL10. This company was established in 2015 and is based ...[Read more]
Industry
Biotechnology
IPO Date
2010-06-21
Stock Exchange
NASDAQ
Ticker
EDSA
According to Edesa Biotech, Inc.’s latest financial reports and current stock price. The company's current ROE is -82.34%. This represents a change of 275.33% compared to the average of -21.94% of the last 4 quarters.
The mean historical ROE of Edesa Biotech, Inc. over the last ten years is -107.82%. The current -82.34% ROE has changed -23.63% with respect to the historical average. Over the past ten years (40 quarters), EDSA's ROE was at its highest in in the June 2018 quarter at -9.34%. The ROE was at its lowest in in the December 2024 quarter at -71.43%.
Average
-107.82%
Median
-81.98%
Minimum
-311.44%
Maximum
-40.82%
Discovering the peaks and valleys of Edesa Biotech, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 162.14%
Maximum Annual ROE = -40.82%
Minimum Annual Increase = -81.47%
Minimum Annual ROE = -311.44%
| Year | ROE | Change |
|---|---|---|
| 2025 | -57.71% | -81.47% |
| 2024 | -311.44% | 162.14% |
| 2023 | -118.81% | -36.42% |
| 2022 | -186.86% | 82.87% |
| 2021 | -102.18% | 6.47% |
| 2020 | -95.97% | 85.37% |
| 2019 | -51.77% | 15.97% |
| 2018 | -44.65% | -34.34% |
| 2017 | -67.99% | 66.58% |
| 2016 | -40.82% | 14.93% |
The current ROE of Edesa Biotech, Inc. (EDSA) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-162.65%
5-year avg
-155.40%
10-year avg
-107.82%
Edesa Biotech, Inc.’s ROE is greater than BioRestorative Therapies, Inc. (-423.84%), greater than Dogwood Therapeutics, Inc. (-35.91%), greater than Cocrystal Pharma, Inc. (-150.61%), greater than OSR Holdings, Inc. (-15.90%), less than Traws Pharma, Inc. (489.90%), greater than Immuron Limited (-43.95%), greater than Ernexa Therapeutics Inc. (-263.68%), less than Evogene Ltd. (937.72%), greater than Sensei Biotherapeutics, Inc. (-283.67%), greater than Imunon, Inc. (-341.23%),
| Company | ROE | Market cap |
|---|---|---|
| -423.84% | $3.68M | |
| -35.91% | $2.96M | |
| -150.61% | $10.20M | |
| -15.90% | $9.63M | |
| 489.90% | $7.77M | |
| -43.95% | $6.83M | |
| -263.68% | $1.95M | |
| 937.72% | $4.52M | |
| -283.67% | $18.59M | |
| -341.23% | $4.59M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Edesa Biotech, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Edesa Biotech, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the ROE?
How can you use the ROE?
What is Edesa Biotech, Inc.'s ROE?
How is the ROE calculated for Edesa Biotech, Inc. (EDSA)?
What is the highest ROE for Edesa Biotech, Inc. (EDSA)?
What is the 3-year average ROE for Edesa Biotech, Inc. (EDSA)?
What is the 5-year average ROE for Edesa Biotech, Inc. (EDSA)?
How does the current ROE for Edesa Biotech, Inc. (EDSA) compare to its historical average?